Search results for: 'biological particip analysis'

02 Sep 2015  |  North America  |  Market Research

Healthcare Transformations Drive Changes in Business Models

Analysis of Innovative and Emerging Business Models in Next Generation Healthcare

Infographics

×

The healthcare industry is on the brink of transformation driven by a shift in the objective of care from treatment to prevention and wellness. Other major paradigm shifts such as the emergence of consumer as the center of the healthcare ecosystem and the need for delivering healthcare services at unconventional locations are creating new and excit...

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects. ...

In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...

31 Aug 2020  |    |  Technology Research

Data Science Impacting the Pharmaceutical Industry Part II: Clinical trial Applications

Enabling faster analysis using advanced tools

Infographics

×

Clinical Trials, the most crucial step in drug discovery has never been in the forefront in adopting new technologies and transforming from the conventional protocols. With the development of AI/ML in the last five years, it has opened up a new horizon for transforming clinical trials. It has been proven that use of AI/ML tools can scan through la...

Healthcare interoperability, the ability of different healthcare systems and applications to seamlessly exchange and use patient health data, is critical to advanced, precise, and personalized healthcare. Data interoperability is crucial to advanced, precise, and personalized healthcare; however, achieving interoperability has been a significant ch...

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprises insights across new developments for antibody-drug conjugates, T-cell engagers, cell and gene therapies, precision immunology and cancer care.The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life science...

The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressure wound therapy (NPWT) devices, bioengineered ski...

The procedure for accurately identifying a biomarker correlation based on a patient s genetic makeup is complex and relies on the expertise and knowledge of an oncologist, decision-support scientist, or other healthcare professional involved in the matching process. Precision oncology aims to provide oncologists with diagnosis, prognosis, and treat...